If you need more lookups,
subscriptions start at $34 USD/month.
Mark de Souza Location
Berkeley, CA, US
Mark de Souza Work
President and CEO @ (January 2022 - Present)
Co-Founder, President @ Willow Neuroscience (January 2016 - June 2025)
Co-Founder and Executive Chairman @ (May 2019 - August 2024)
Co-Founder, Board member @ Phoenicis Therapeutics (February 2021 - July 2024)
Co-Founder and Board Member @ NFlection Therapeutics, Inc. (January 2014 - June 2022)
COO and CFO @ (January 2019 - December 2021)
Co-Founder, President and CEO @ Chromaderm Inc (merged with Dermbiont, Inc.) (October 2015 - August 2021)
Co-Founder, President and CEO @ FIBRX Derm, Inc. (merged into Phoenicis Therapeutics) (October 2018 - February 2021)
Co-Founder and Chief Executive Officer @ SeylanMED, LLC (merged with Dermbiont) (February 2018 - October 2020)
Executive Chairman @ PellePharm, a BridgeBio company (January 2015 - December 2017)
Consultant @ (February 2013 - February 2014)
Co-Founder, President and CEO @ Lotus Tissue Repair, Inc. (acquired by Shire) (June 2011 - February 2013)
Vice President, Business Development @ Dyax Corp. (acquired by Shire) (January 2001 - January 2011)
Mark de Souza Skills
Program Management
Biotechnology
Management
Sales
Business Analysis
Mark de Souza Summary
Mark de Souza, based in Berkeley, CA, US, is currently a President and CEO at SonALAsense. Mark de Souza brings experience from previous roles at Willow Neuroscience, Flightpath Biosciences, Inc, Phoenicis Therapeutics and NFlection Therapeutics, Inc.. With a robust skill set that includes Program Management, Biotechnology, Management, Sales, Business Analysis and more. Mark de Souza has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark de Souza?
Find contact details for 700 million professionals.